Download PDF

Other users also viewed these articles

O- 5 HCC RISK SCORE PRE AND POST SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED FOR CHRONIC HEPATITIS C Marcus Vinícius de Acevedo Garcia Gomes; Diogo Delgado Dotta; Manuella Andrade Oliveira Sobral; Carla Brígido Oliveira; Isabela Bodaczny Taliberti; Nadjanine Linhares Casimiro; Glenda Alves Pereira Oliveira; André Luís Ferreira Bruder; Rosa Maria Nascimento Marcusso; Betania da Silva Rocha; Alexandre Trazzi; PATRICIA ZITELLI; Mário Guimarães Pessoa;
Ann Hepatol. 2024;29 Supl 1:
PROTECTIVE ROLE OF MTARC1 RS2642438 POLYMORPHISM AGAINST FIBROSIS PROGRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) Sofia Rocha; Claudia Oliveira Marques; Jose Tadeu Stefano; Raymundo Soares Azevedo; Michele Soares Gouvea; Patricia Momoyo Zitelli; Mario Guimaraes Pessoa; Joao Renato Rebello Pinho;
Ann Hepatol. 2025;30 Supl 2:
VALIDATION OF AGILE-3+ AND AGILE-4 SCORES FOR NONINVASIVE DETECTION OF FIBROSIS AND CIRRHOSIS IN METABOLIC DYSFUNCTION¿ASSOCIATED STEATOTIC LIVER DISEASE IN LATIN AMERICA Carlos Esteban Coronel Castillo; Luis Antonio Diaz Piga; Natalia Baeza; Francisco Idalsoaga; Daniel Cabrera Garcia; Fernando Javier Barreyro; Sebastian Marciano; Jorge Martinez Morales; Cristiane Villela Nogueira; Nathalie Leite; Gil Salles; Claudia Regina Cardoso; Claudia Alves Couto; Rafael Theodoro; Mísia Joyner de Sousa Dias Monteiro; Mario Guimaraes Pessoa; Mario Reis Alvares-da Silva; Bruno Basso; Gabriella Jonko; Fatima Higuera de la Tijera; Constanza D. Sabate; Manuel Mendizabal; Mazen Noureddin; Naim Alkhouri; Winston Dunn; Rohit Loomba; Claudia P. Oliveira; Adrian Gadano; Marco Arrese; Juan Pablo Arab;
Ann Hepatol. 2025;30 Supl 2: